Profit and Loss Results Results Snapshot
Figures in Cr
Consolidated - Profit And Loss Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
No of Months
12
12
12
12
12
12
Operating Income
503.00
370.00
307.00
251.00
456.00
262.00
Less :Inter divisional transfers
0.00
0.00
0.00
0.00
0.00
0.00
Less: Excise
0.00
0.00
0.00
0.00
0.00
0.00
Net Sales
503.00
370.00
307.00
251.00
456.00
262.00
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
1.00
-1.00
-3.00
-2.00
0.00
Raw Materials Consumed
258.00
181.00
154.00
113.00
203.00
165.00
Power & Fuel Cost
26.00
23.00
17.00
12.00
11.00
6.00
Employee Cost
54.00
43.00
32.00
29.00
20.00
15.00
Operating Expenses
2.00
3.00
6.00
5.00
4.00
3.00
General and Administration Expenses
-1.00
-1.00
-1.00
-1.00
-1.00
-1.00
Selling and Distribution Expenses
17.00
16.00
7.00
12.00
27.00
24.00
Cost of Software developments
0.00
0.00
0.00
0.00
0.00
0.00
Miscellaneous Expenses
1.00
2.00
2.00
1.00
0.00
1.00
Expenses Capitalised
0.00
0.00
0.00
0.00
0.00
0.00
Total Expenditure
384.00
289.00
240.00
190.00
284.00
233.00
Operating Profit (PBDIT) excl Other Income
118.00
80.00
66.00
60.00
171.00
28.00
Other Income
2.00
1.00
1.00
2.00
3.00
1.00
Operating Profit (PBDIT)
121.00
82.00
68.00
63.00
175.00
30.00
Interest
10.00
9.00
10.00
6.00
2.00
2.00
Profit before Depriciation and Tax
110.00
72.00
57.00
57.00
172.00
27.00
Depreciation
19.00
18.00
19.00
14.00
10.00
6.00
Profit Before Taxation & Exceptional Items
90.00
54.00
38.00
42.00
161.00
21.00
Exceptional Income / Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Profit Before Tax
89.00
54.00
31.00
25.00
161.00
21.00
Provision for Tax
22.00
14.00
7.00
6.00
41.00
6.00
Profit After Tax
67.00
39.00
23.00
19.00
119.00
14.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
Adj to Profit After Tax
0.00
0.00
0.00
0.00
0.00
0.00
Profit Balance B/F
242.00
202.00
179.00
160.00
42.00
26.00
Profit Available for appropriations
310.00
242.00
203.00
179.00
162.00
41.00
Appropriations
310.00
242.00
203.00
179.00
162.00
41.00
Equity Dividend (%)
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
Earnings Per Share
64.90
38.36
22.76
18.16
115.12
14.60
Profit And Loss Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2026 is 35.90% vs 20.52% in Mar 2025
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2026 is 47.09% vs 21.22% in Mar 2025
Interest
YoY Growth in year ended Mar 2026 is 11.06% vs -4.90% in Mar 2025
Profit After Tax
YoY Growth in year ended Mar 2026 is 69.20% vs 68.54% in Mar 2025
Compare Profit and Loss Results of Kwality Pharma
Figures in Cr
consolidated - Profit And Loss Results
Change(INR)
Change(%)
No of Months
12
12
Operating Income
503.00
835.00
-332.00
-39.76%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
52.00
-52.00
-100.00%
Net Sales
503.00
782.00
-279.00
-35.68%
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
-64.00
64.00
100.00%
Raw Materials Consumed
258.00
501.00
-243.00
-48.50%
Power & Fuel Cost
26.00
56.00
-30.00
-53.57%
Employee Cost
54.00
80.00
-26.00
-32.50%
Operating Expenses
2.00
29.00
-27.00
-93.10%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
17.00
13.00
4.00
30.77%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
1.00
2.00
-1.00
-50.00%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
384.00
643.00
-259.00
-40.28%
Operating Profit (PBDIT) excl Other Income
118.00
138.00
-20.00
-14.49%
Other Income
2.00
6.00
-4.00
-66.67%
Operating Profit (PBDIT)
121.00
145.00
-24.00
-16.55%
Interest
10.00
18.00
-8.00
-44.44%
Profit before Depriciation and Tax
110.00
126.00
-16.00
-12.70%
Depreciation
19.00
34.00
-15.00
-44.12%
Profit Before Taxation & Exceptional Items
90.00
92.00
-2.00
-2.17%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
89.00
92.00
-3.00
-3.26%
Provision for Tax
22.00
24.00
-2.00
-8.33%
Profit After Tax
67.00
67.00
0.00
0.00%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
242.00
324.00
-82.00
-25.31%
Profit Available for appropriations
310.00
394.00
-84.00
-21.32%
Appropriations
310.00
394.00
-84.00
-21.32%
Equity Dividend (%)
0%
40%
-40.00
Earnings Per Share
64.9
8.16
56.74
695.34%
Profit And Loss - Net Sales
Net Sales 503.08 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 35.90% vs 20.52% in Mar 2025
Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 118.24 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 47.09% vs 21.22% in Mar 2025
Profit And Loss - Interest
Interest 10.97 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 11.06% vs -4.90% in Mar 2025
Profit And Loss - Profit After Tax
Profit After Tax 67.35 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 69.20% vs 68.54% in Mar 2025
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
